Funding
Series D · Healthtech

Grow Therapy raises $150m Series D

TCV, Goldman Sachs Alternatives Growth Equity, BCI and other investors participated in the financing.

Updated Oct 16, 2026By RoundOS Funding desk

Grow Therapy raised $150 million in Series D financing on March 3. Participants included TCV, Goldman Sachs Alternatives Growth Equity, BCI, Menlo Ventures, Sequoia Capital, SignalFire and Transformation Capital. The company supports providers delivering in-person and online therapy and psychiatric care.

Funding history

Series D · This round$150M

Sources

  1. Grow Therapyprojectstartups.com
  2. prnewswire.com

Similar rounds

All Healthtech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Knowledge Work

Tokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.

¥4.8BSeries C debt second close · Oct 23, 2026
Fairy Devices

Tokyo company developing wearable devices and remote-assistance software for industrial field workers.

UndisclosedJICN equity investment · Oct 23, 2026

Related